# NUTEX HEALTH INC. (NUTX) · Edgar & Edgarette company card

> Nutex Health (NUTX) grew revenue 82.4% in FY2025 to $875 million, operating margin 31.5% against a 7.9% median for business services, equity 35.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1479681 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/NUTX) · [JSON](https://www.pops4.com/boards/company/NUTX.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $875M |
| Revenue growth, 1 year | 82.4% |
| Revenue growth per year | 27.5% |
| Operating margin | 31.5% (prior year 27.2%) |
| Net margin | 20.6% |
| Operating cash flow | $248M |
| Capital spending | $3M |
| Free cash flow | $246M |
| Cash | $186M |
| Long-term debt | $43M |
| Total assets | $919M |
| Total equity | $329M |
| Equity ÷ assets | 35.9% |
| Return on equity | 54.7% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 4.42 (safe zone)
- Piotroski F: 8 of 9 (strong)
- Health Harbor boat: Weathered boat · two warning signs · filed late quarterly report notice, cybersecurity incident in the last 12 months; revenue is hard to predict: its 80% range is ±53%
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $875.3M (FY2025), total debt $42.5M. Experience: revenue up 82.4% on the year, up 27.5% a year over 4 years; operating margin 31.5%, up from 27.2%. Soundness: equity 35.9% of assets, return on equity 54.7%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $817.2M and $2.7B next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $606.1M to $3.6B. A statistical range, not company guidance. Against peers (70 filers, $50M+ revenue, services-business services, nec): operating margin 31.5% against a 7.9% median; growth 82.4% against 10.2%.

Range logged 2026-09-29, receipt 0998076b94c5ea09, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item NT 10-Q Late quarterly report notice: 1, latest 2025-11-17 ([filing](https://www.sec.gov/Archives/edgar/data/1479681/000162828025052654/0001628280-25-052654-index.htm))
- Item 1.05 Cybersecurity incident: 1, latest 2026-08-31 ([filing](https://www.sec.gov/Archives/edgar/data/1479681/000162828026059602/0001628280-26-059602-index.htm))

## Recent filings

- 8-K · filed 2026-09-11 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1479681/000162828026061432/0001628280-26-061432-index.htm)
- 8-K · filed 2026-08-31 · 1.05 Material Cybersecurity Incidents · [filing](https://www.sec.gov/Archives/edgar/data/1479681/000162828026059602/0001628280-26-059602-index.htm)
- 8-K · filed 2026-08-24 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1479681/000162828026058606/0001628280-26-058606-index.htm)
- 8-K · filed 2026-08-13 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1479681/000162828026056696/0001628280-26-056696-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1479681/000162828026054274/0001628280-26-054274-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1479681/000162828026054268/0001628280-26-054268-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001479681.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1479681

## Cite

POPS4, Edgar & Edgarette: NUTEX HEALTH INC. (NUTX) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/NUTX. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.